Publicaciones en colaboración con investigadores/as de Universidad Miguel Hernández de Elche (3)

2024

  1. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

2022

  1. Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care—APHOSDIAB—COVID-19 Multicenter Study

    Journal of Clinical Medicine, Vol. 11, Núm. 8

  2. Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 209-218